• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.33% Nasdaq Up1.33%

    Tonix Pharmaceuticals Holding Corp. (TNXP)

    -NasdaqGM
    1.99 Down 0.12(5.69%) Jun 30, 4:00PM EDT
    ProfileGet Profile for:
    Tonix Pharmaceuticals Holding Corp.
    509 Madison Avenue
    Suite 306
    New York, NY 10022
    United States - Map
    Phone: 212-980-9155
    Fax: 212-923-5700
    Website: http://www.tonixpharma.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:28

    Business Summary 

    Tonix Pharmaceuticals Holding Corp. engages in developing medicines for common disorders of the central nervous system. These disorders are characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden. The company's lead product candidate includes TNX-102 SL, a cyclobenzaprine HCl sublingual tablet, which is in Phase III clinical stage for the treatment of fibromyalgia; and Phase II clinical stage for the treatment of post-traumatic stress disorder. It also engages in developing TNX-301, a fixed dose combination drug product that contains disulfiram and selegiline for the treatment of alcohol use disorders, as well as biodefense development programs for protection from smallpox virus and radiation injury. Tonix Pharmaceuticals Holding Corp. was founded in 2007 and is headquartered in New York, New York.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Tonix Pharmaceuticals Holding Corp.

    Key Executives 
     PayExercised
    Dr. Seth Lederman M.D., 58
    Co-Founder, Chairman, and Chief Exec. Officer
    675.00K0.00
    Dr. Donald W. Landry M.D., Ph.D., 61
    Co-Founder and Director
    N/AN/A
    Mrs. Jessica Edgar Morris ,
    Exec. VP of Operations
    352.00K0.00
    Dr. Bruce L. Daugherty Ph.D., M.B.A., 58
    Chief Scientific Officer, Controller and Sec.
    297.00K0.00
    Dr. Gregory M. Sullivan M.D., 50
    Chief Medical Officer
    282.00K0.00
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders